Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virios Therapeutics Inc (NQ: VIRI )

0.1550 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Virios Therapeutics Inc

< Previous 1 2 3 4 5 6 7 Next >
Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia
From Virios Therapeutics, Inc.
Via Business Wire
Virios Therapeutics: Q1 Earnings Insights
Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
From Virios Therapeutics, Inc.
Via Business Wire
Preview: Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios... 
Via Benzinga
Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022
From Virios Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
Virios Therapeutics Completes Enrollment of 425 Patients in Phase 2b “FORTRESS” Clinical Trial for Fibromyalgia
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Virios Therapeutics: Q4 Earnings Insights
Virios Therapeutics (NASDAQ:VIRI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
From Virios Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
A Preview Of Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease?
Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. 
Via Benzinga
Benzinga Announces This Week's All Access Guests
Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:... 
Via Benzinga
RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
ORLANDO, FL / ACCESSWIRE / January 26, 2022 / RedChip Companies, Inc., an international investor relations, media, and research firm focused on microcap and small-cap companies, is pleased to announce... 
From RedChip
Via AccessWire
Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
From Virios Therapeutics, Inc.
Via Business Wire
64 Biggest Movers From Yesterday
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... 
Via Benzinga
Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From Virios Therapeutics, Inc. (VIRI)
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
Virios Therapeutics Announces New Social Media Profiles
From Virios Therapeutics, Inc.
Via Business Wire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
Exposures Cannabis
Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview
From Virios Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.